Lucid Group Inc vs Roivant Sciences Ltd. Common Shares — how do they compare? Lucid Group Inc trades at $3.79 (market cap $1.51B), while Roivant Sciences Ltd. Common Shares trades at $35.44 (market cap $24.72B). The key difference: Roivant Sciences Ltd. Common Shares is far larger — about 16.4× Lucid Group Inc's market cap, and Roivant Sciences Ltd. Common Shares is trading nearer its 52-week high, Lucid Group Inc nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Lucid Group Inc for 45 Days and Roivant Sciences Ltd. Common Shares for 1 Days on average.
| LCID | ROIV | |
|---|---|---|
Market Cap | $1.51B | $24.72B |
Volume | 12,333,745 | 6,279,442 |
Sector | Consumer Cyclical | Health |
52-Week High | $21.92 | $41.81 |
52-Week Low | $3.79 | $16.04 |
Typical Hold Time | 45 Days | 1 Days |
Enterprise Value | $4.40B | $20.99B |
Signals from Pluang's Aura AI — not financial advice
Lucid Group (LCID) trades at $3.82, down 1.8% with a bearish technical outlook. The company faces significant financial challenges with negative profit margins (-249.21% net income margin) and consecutive earnings misses. Recent developments include strategic partnerships for autonomous vehicles and software updates, but cash burn remains elevated at -$2.93B operating cash flow in 2025.
LCID presents high-risk turnaround potential with analyst consensus target of $7.60 (99% upside) but requires successful execution on cost savings and new vehicle launches. Key risks include persistent cash burn, production delays, and competitive EV market pressures. The stock's viability hinges on management's ability to achieve targeted $1.4B cost savings and deliver the delayed Cosmos SUV.
No Aura AI signal available yet.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
No sentiment data available yet.
Latest headlines on both assets
Lucid Group Inc is a technology and automotive company. It develops the next generation of electric vehicle (EV) technologies. It is a vertically integrated company that designs, engineers, and builds electric vehicles, EV powertrains, and battery systems in-house using our own equipment and factory.
Read more on LCID →Roivant Sciences develops medicines by building and supporting biotechnology subsidiaries, known as Vants. Its programs span areas such as immunology, neuroscience, and rare diseases.
Read more on ROIV →